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INTRODUCTION 
   Headache disorders are ranked amongst the ten most disabling 
conditions in the world by World Health Organisation (WHO) .1  Headache 
is one of the most common complaint encountered in general medical 
practice, accounting for 4% of outpatient physician visits. It has the dubious 
distinction of being the earliest recognized symptom of a wide spectrum of 
diseases. 2  
  Headache has been referred to in many ancient literatures. The earliest 
reference dates back to a papyrus (ancient medical text book) as old as 3500 
BC in the tomb of Thebes that mention the king in the tomb had suffered all 
his life of a sickness of half head.  
Hippocrates (460-377BC) wrote a description of a disease of the 
hemicrania that relieved on vomiting.  
According to different population based studies , over 70% of the 
general population  experience atleast one headache per year and about 15% 
consult a physician. 3 
The global prevalence of active headache diseases in the adult 
population is 46%. About 3% of the world’s population is affected by 
chronic headache that lasts for more than 15 days per month. 1, 4 
While headache has been an unaddressed cause of morbidity around 
the world, it has remained largely unrecognised in the developing world. 1, 5 
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Most clinical and epidemiological studies have originated in developed 
countries and there is scarce literature to support treatment guidelines or 
public health interventions to deal with headache in low and middle income 
countries where 85% of the world’s population lives. 1 
Inspite of the fact that headache is one of the most common of medical 
complaints , most headaches in practice continue to be under diagnosed and 
under treated. Even today many treating physicians feel that nothing much 
can be done for headache patients! And since more than 90% of headaches 
seen in practice are primary headaches , it is to be realised that matters have 
come a long way in the last decade and there is now enough evidence to 
prove that primary headaches are a genuine potentially treatable biological 
problem.  
It is therefore important that clinicians do not err in making the right 
diagnosis and choosing the correct drug options. 6 
This work of dissertation has been done with an aim at  documenting  
the patients presenting with different types of chronic  headache, their 
clinical profile, and diagnostic modalities, at the Neurology department, 
Govt. Royapettah Hospital, Chennai during a one year period. 
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AIM OF THE STUDY 
 
1. To classify and to study the various types of Chronic  Headache. 
2. To study the clinical profile of Chronic Headache. 
3. To study the radiological profile of Chronic Headache.  
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REVIEW OF LITERATURE 
Headache is one of the most common types of recurrent pain as well 
as one of the most frequent symptoms in neurology. Although almost 
everyone get occasional headaches, there are well defined headache 
disorders that vary in incidence , prevalence and duration. These disorders 
are usually divided into two broad categories : primary headache and 
secondary headache.  In secondary disorders, headaches are attributed to 
another condition , such as brain tumour or head injury ; for the primary 
disorders the headache is not due to another condition. 7 
CHRONIC HEADACHE 
Chronic  headache / Chronic daily headache is defined as  frequent 
headache occurring more than 15 days/month for over 3 months including 
those headaches associated with medication overuse. Such headaches may be 
primary / secondary. 8,9  
Chronic headache affects up to 4% of adults and between 1% and 2% 
of middle school children. 10,11 The headache characteristics in patients with 
chronic headache can vary between patients as well as within individual 
patient. Their headache may present as severe intermittent migraine attacks , 
intermittent low severity headaches , continuous headache pains , or as a 
combination of these headache types. This variation continues to make this 
condition   remarkably challenging to understand and to treat.10 
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In 1994 and 1996,   Siberstein and Lipton subdivided Primary CDH of 
long duration in to  
- Transformed migraine 
 - Chronic tension type headache, 
 - Hemicrania continua and 
 - New daily persistent headache. 9,12 
In 2004, the International headache society published criteria for 
Chronic migraine, hemicrania continua, new daily persistent headache , and 
for chronic tension type headache. The IHS also published criteria for 
medication- overuse headache as a type of secondary headache disorder. 13 
There are no IHS  criteria for transformed migraine. Hence chronic migraine 
is considered as the subset for transformed migraine. 14 
Primary Chronic Daily Headache (CDH), defined as ≥ 15 headache 
days / month for > 3 months in the absence of organic pathology . 15 Primary 
CDH  is divided in to shorter duration headaches( < 4 hrs) such as chronic 
cluster headache , chronic paroxysmal hemicrania and hypnic headache and 
longer duration headache (> 4 hours)  includes Chronic migraine(CM) , 
Chronic  tension type headache ( CTTH), New daily persistent headache 
(NDPH), and Hemicrania continua. Most CDH sufferers in the general 
population have chronic tension type headache or migrainous headache. 16 
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Secondary CDHs occur 15 or more times a month and have some 
identifiable underlying cause. Secondary cause of frequent headaches 
include post- traumatic headache, cervical spine disorders , headache 
associated with vascular disorders , headache associated with non vascular 
intracranial disorders, and other disorders (i.e., temporo mandibular joint 
disorder or sinus infection. 8 
Epidemiology 
The prevalence rate of CDH in the general population averages 3% - 
4% .The prevalence in childhood or adolescence is lower, averaging about 
1% - 2%. Prevalence in the elderly is similar to that seen in the general 
population. 16 The prevalence of CDH with medication overuse was found to 
increase with age, reaching its maximum during the sixth decade of life. The 
prevalence of transformed migraine in many studies ranged from 1.0-2.4%.  
CDH affects more women than men by a factor of roughly 2:1. 14,17 
 Currently 40-50% of primary headaches seen in hospital OPD and 60-
70% seen in doctors’ clinic fall within this category. 18 
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CHRONIC DAILY HEADACHE 
APPROACH TO DIAGNOSIS 
 
Headache > 15 days/ month for > 3 months 
               
 History, Examination, Chest X-ray, Hematology, CT/MRI, CSF study 
                          
                 Rule out secondary CDH Æ   yes Æ     diagnose 
                       
                                                     No 
                 
                                      Primary CDH -Classify 
                
      < 4 hours duration                                     > 4 hours duration 
Chronic cluster headache                                    Chronic migraine 
Paroxysmal hemicrania                                          CTTH 
Hypnic headache                                                   NDPH 
Idiopathic stabbing headache                               Hemicrania continua8 
 There are some modifiable and non-modifiable factors that appears to 
influence risk of headache progression. 
Non modifiable risk factors for CDH:- 
• Age and gender  
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• Socioeconomic status 
• Marital status 
Modifiable risk factors for CDH:- 
 Obesity 
 Snoring 
 Comorbid pain 
 Head or neck injury 
 Caffeine intake 
 Medication use16 
 Stressful Life event19 
Pathophysiology 
                Although the source of pain in primary CDH is unknown and may 
be dependent on the subtype, research findings suggest that the following 
mechanisms, alone or in combination, contribute to the process. 
1. Abnormal excitation of peripheral nociceptive afferent fibers in the 
meninges;  
2. Enhanced responsiveness of trigeminal nucleus caudalis neurons;  
3. Decreased pain modulation from higher centers such as the 
pariaqueductal gray matter;  
4.  Spontaneous central pain generated by activation of the “on cells” in 
the medulla;  
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5.  Decreased serotonin levels; and  
6. Central sensitization. 20  
Sarchielli and colleagues (2001) reported that the CSF of patients with 
CDH contained a high level of nerve growth factor and substance P 
compared with controls. Gallai and associated (2003) demonstrated a 
significant increase in glutamate and nitrite levels in the CSF of patients with 
CDH.  
The increase in nitrites was accompanied by a rise in cyclic guanosine 
monophosphate (cGMP). This suggests a central disturbance of the receptors 
for glutamate, N-methyl-D-aspartate (NMDA) receptors. Substance P and 
calcitonin - gene-related peptide (CGRP) were also elevated in the CSF 
compared with that of control subjects. Whether these changes indicate a 
causative role or are a response to chronic pain remains open to conjecture. 21 
For the past 15 years, the first edition of the diagnostic criteria of the 
International Headache Society (ICHD-1) has been the accepted standard. 
The second edition of the International classification of Headache 
Disorders(ICHD-2) reflects our improved understanding of some disorders 
and the identification of new disorders (Headache Classification 
Subcommittee of the International Headache Society 2004). Like its 
predecessor, the ICHD-2 separates headache into primary and secondary 
disorders. 7 
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INTERNATIONAL CLASSIFICATION OF HEADACHE 
DISORDERS-2 (ICHD-2) 
PRIMARY HEADACHES 
1 Migraine 
1.1 Migraine without aura  
1.2 Migraine with aura 
1.3 Childhood periodic symptoms that are commonly precursors of 
migraine 
1.4 Retinal migraine 
1.5 Complications of migraine 
1.5.1  Chronic migraine 
1.6  Probable migraine 
1.6.1  Probable migraine without aura 
1.6.2  Probable migraine with aura 
2  Tension Type Headache 
 2.1   Infrequent episodic Tension Type 
 2.2   Frequent episodic Tension Type 
2.3 Chronic Tension Type 
2.3.1 Chronic tension-type associated with pericranial tenderness 
2.3.2 Chronic tension-type not associated with pericranial 
tenderness 
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2.4 Probable Tension Type 
3  Cluster Headache and other trigeminal autonomic cephalalgias 
 3.1 Cluster Headache 
  3.1.1 Episodic Cluster Headache 
  3.1.2 Chronic Cluster Headache 
 3.2 Paroxysmal hemicrania 
 3.3 Short-lasting unilateral neuralgiform headache attacks with 
      conjunctival   injection and tearing (SUNCT) 
 3.4 Probable trigeminal autonomic cephalagia 
4  Other Primary Headaches 
 4.1 Primary stabbing headache 
 4.2 Primary cough headache 
 4.3 Primary exertional headache 
 4.4 Primary headache associated with sexual activity 
 4.5 Hypnic headache 
 4.6 Primary thunderclap headache 
 4.7 Hemicrania continua 
 4.8 New daily persistent headache 
SECONDARY HEADACHES 
5 Headache attributed to head and/ or neck trauma 
6 Headache attributed to cranial or cervical vascular disorders 
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7 Headache attributed to non- vascular intracranial  disorder 
8 Headache attributed to its substance or its withdrawal  
9 Headache attributed to infection 
10 Headache attributed to disorder of homeostasis 
11 Headache or facial attributed to disorder of cranium , neck ,eyes , ears , 
nose , mouth , sinuses , teeth, mouth , or other facial or cranial structures 
12 Headache attributed to psychiatric disorder 
13 Cranial neuralgias and central causes of facial pain.13 
 Migraine(1.0) 
Migraine is a neurological disorder characterised by episodic attacks 
of headache and associated symptoms.7 Migraine is a common and disabling 
disorder that may be divided into 2 broad groups based on the number of 
headache days. If attacks occur less than 15 days per month the term 
episodic migraine is applied; when headaches occur on 15 or more days per 
month the terms chronic migraine or transformed migraine is used. 22 
Epidemiology:- 
Epidemiological studies have documented its prevalence and high 
socioeconomic and personal impacts. It is now ranked by the World Health 
Organisation as number 19 among all diseases world wide causing disability. 
It exerts the greatest impact on quality of life as defined by increased 
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absenteeism from school or work, and more frequent consultation with 
physicians. 13 
 Migraine with or without aura is remarkably common condition. 
Migraine incidence is more common in females than males. It usually begins 
in adolescence. More than 80% the onset is before 30 years of age. Although 
migraine usually diminishes in severity and frequency with age it may 
actually worsens in some postmenopausal women  and estrogen therapy may 
increase or paradoxically diminish the incidence of headaches. 
 Pathophysiology :- 
  Burstein and colleagues   showed that approximately 75% of migraine 
sufferers develop central sensitization (sensitization of the second order 
trigeminal neuron, which is clinically manifested by the development of 
cutaneous allodynia) during the course of a migraine attack. Central 
sensitization appears to be associated with triptan refractoriness. Central 
sensitization explains the progression of attacks but also may play a role in 
the progression of the disease itself. It is suggested that repeated central 
sensitization episodes are associated with permanent neuronal damage, 
preventive treatment refractoriness, and disease progression. 23,24,25 
1. Central sensitization of pain-procession neurons in the central nervous 
system by repeated activation of trigeminal nociceptors 
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2. Depletion of serotonin and  noradrenaline  in the endogenous pain-
control system, permitting unrestrained inflow of afferent 
impulses.20,26 
In the study by Yarnitsky and colleagues (2003), blockade of 
parasympathetic outflow to cerebral and meningeal blood vessels by 
intranasal lidocaine eased the pain of migraine headache in some patients, 
whereas allodynia continue to worsen. This was interpreted as indicating that 
the inflow of nociceptive  impulses from dilated vessels in the brain and dura 
mater during migraine headache had sensitized second-order neurons and 
then third-order neurons to cause allodynia. 27 
There is considerable overlap in mechanisms mediating migraine 
headache pain and sustained opioid-induced paradoxical pain. One change 
that occurs following chronic morphine is increased expression of calcitonin 
gene-related peptide (CGRP) in primary afferent neurons. Central changes 
induced by chronic morphine use include increased descending facilitation 
from the rostral ventromedial medulla and increased excitatory 
neurotransmission at the level of the dorsal horn. During migraine, CGRP 
release from primary afferent neurons innervation the intracranial 
vasculature contributes to neurogenic vasodilatation, and increased 
excitability of dorsal horn neurons is evident.  Descending facilitation from 
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the rostral ventromedial medulla may contribute to this increased excitability 
and hypersensitivity. 28 
Using high resolution magnetic resonance imaging (MRI) techniques, 
abnormally high levels of non-heme iron were detected in the midbrain 
periaqueductal gray (PAG) of patients with episodic migraine between 
attacks, as well as in CDH patients who were over using acute medications. 
Iron levels increased with the duration of illness. 29 
    Migraine is divided into six major categories, namely  
(i) Migraine without aura(1.1) 
(ii) Migraine with aura(1.2) 
(iii) Childhood peridodic symptoms that are commonly 
precursors of migraine(1.3) 
(iv) Retinal migraine(1.4) 
(v) Complications  of migraine(1.5) 
Chronic migraine (1.5.1) 
(vi) Probable migraine.13 
1.1 Migraine without aura 
Previously used terms:  
 Common migraine,  hemicrania simplex 
Description 
 Recurrent headache disorder manifesting in attacks lasting 4-72 hours. 
Typical characteristics of the headache are unilateral location , pulsating 
quality , moderate or severe intensity , aggravation by routine physical 
activity and association with nausea and/or photophobia and phonophobia. 
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 ICHD-2 diagnostic criteria for migraine without aura(1.1) 
A. Atleast 5 attacks fulfilling criteria B-D 
B. Headache attacks lasting 4 -72 hours(untreated or unsuccessfully treated) 
C. Headache has atleast two of the following characteristics 
a. Unilateral location 
b. Pulsating quality( Throbbing or varying with the heartbeat at 
rest or with movement) 
c. Moderate or severe pain intensity 
d. Aggravation by or causing avoidance of routine physical 
activity (i.e. walking or climbing stairs) 
D. During headache atleast one of the following 
a. Nausea and / or vomiting 
b. Photophobia and Phonophobia 
E. Not attributed to another disorder 
Migraine without aura is the commonest subtype of migraine. It has a higher 
average attack frequency and is usually more disabling than 1.2 Migraine 
with aura.13, 30, 31, 32 
1.2 Migraine with aura 
Previously used terms 
 Classical migraine , ophthalmic , hemiparesthetic , hemiplegic or 
aphasic migraine , complicated migraine 
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Description 
 Recurrent disorder manifesting in attacks of  reversible  focal 
neurological symptoms that usually develop gradually over 5 – 20 minutes 
and last for less than 60 minutes. Headache with the features “ migraine 
without aura” usually follows the aura symptoms. Less commonly , 
headache lacks migrainous feature or its completely absent (i.e., the aura 
may occur without any subsequent sequelae) 
Diagnostic criteria 
 A.  Atleast 2 attacks fulfilling criteria B-E 
 B.  Fully reversible visual and/or sensory and / or speech symptoms 
but no motor weakness 
 C. Atleast two of the following 
  1. Homonymous visual symptoms including positive features( 
i.e flickering lights, spots, lines)  and/or negative features (i.e. loss of vision) 
and/or unilateral sensory symptoms including positive features(i.e. pins and 
needles) and / or negative features( i.e. numbness) 
  2. Atleast one symptom develop gradually over ≥ 5 min and / or 
different symptoms occur in succession 
  3. Each symptom lasts ≥ 5 min and ≤ 60 min 
 D. Headache meets criteria B-D for migraine without aura (1.1) begins 
during the aura or follows aura within 60 min 
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 E.  Not attributed to another disorder.13, 33 
 1.5.1 Chronic migraine:-  
Chronic migraine is defined as the presence of headache meets criteria 
for migraine without aura for at least 15 days/ month for greater than 3 
months. 
Chronic migraine is now recognised as one of the 4 types of primary 
chronic daily headache of long duration , a syndrome defined by primary 
headaches 15 or more days per month for at least 3 months with attacks that 
last 4 hours or more per day on average. 34, 35 
  Diagnostic Criteria:- 
A. Headache fulfilling criteria C & D for 1.1 migraine without aura on   
>15 days > 3 months 
B. Not attributable to another disorder.9, 13, 19 
    1.6.5    Probable chronic migraine:- 
             Criteria:- 
A. Headache fulfilling criteria C and D for migraine without aura on > 15 
days/month for > 3 months. 
B. Not attributed to another disorder but with in the last 2 months 
medication overuse should be present but should not fulfil the criteria 
for medication overuse headache. 13 
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      TREATMENT STRATEGIES FOR CHRONIC MIGRAINE 
One of the most important benefits to a workable definition for CM is 
the ability for these patients to have a defined set of inclusion criteria for 
their diagnosis, making possible the standardization of clinical trials aimed at 
the treatment of CM. 36 
Nonpharmacological measures 
Patients should be encouraged to eat, sleep, and exercise in a regular 
pattern. Caffeine consumption should be limited. Co morbid depression and 
anxiety must be addressed. Behavioural therapy (eg, biofeedback, relaxation, 
cognitive behavioural therapy) is effective for managing primary headaches 
such as migraine and also may help in the management of CM. Patients who 
had received biofeedback-assisted relaxation in addition to pharmacological 
therapy had greater sustained improvement on two out of three outcome 
measures (ie, fewer headache days and reduced intake of analgesic 
medications) and fewer relapses. 36 
Pharmacologic management 
1 Amitriptyline 
2 Fluoxetine 
3 Tizanidine 
4 Gabapentin 
5 Topiramate 
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6 Botulinum Toxin Type A 
7 Divalproex Sodium 
  Procedural and surgical options 
1 Greater occipital nerve blockade 
2 Occipital nerve stimulation 
3 Vagal nerve stimulation 36 
 TENSION-TYPE HEADACHE (TTH) (2.0) 
 Tension-type headache is the most prevalent form of primary 
headache . For the individual sufferer, the tension-type headache is less 
disabling than migraine or cluster headache, but from a social perspective it 
is important because of its high prevalence.  
Epidemiology 
 TTH varies considerably in frequency and duration, from rare , short 
lasting episodes of discomfort to frequent, long-lasting , or even continuous 
disabling headaches. Its lifetime prevalence in the general population ranges 
in different studies from 30 to 78%. 
  Chronic tension headache is a serious disease causing decreased 
quality of life and high disability, high personal and socioeconomic costs37, 38 
Pathophysiology:- 
Srikiatkhachorn and Anthony (1996) demonstrated that the blood-
platelet serotonin level was low in patients with chronic tension-type 
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headache treated with analgesics. This may reflect depletion in central 
serotonergic pathways known to be important in pain control. 26 
It recently was demonstrated that depression increases vulnerability to 
TTH in patients who have frequent headaches during and after a laboratory 
stress test and that the induced headache was associated with elevated 
pericranial muscle tenderness. 39  
Pericranial myofascial tissues are considerably more tender in patients 
who have TTH than in healthy subjects, and that the tenderness is positively 
associated with the intensity and the frequency of TTH 40 
The increased myofascial pain sensitivity in TTH could be the result 
of release of inflammatory mediators resulting in excitation and sensitization 
of peripheral sensory afferents.  
The increased myofascial pain sensitivity in TTH also could be caused 
by central factors, such as sensitization of second-order neurons at the level 
of the spinal dorsal horn/trigeminal nucleus, sensitization of supraspinal 
neurons, and increased antinoceceptive activity from supraspinal         
structures. 41 
    ICHD-2 distinguishes three forms of tension-type headache:  
1 Infrequent episodic (2.1, < 1 attack per month) 
2 Frequent episodic (2.2 , 1- 14 attacks per month 
3 Chronic (2.3 , > 15 attacks per month 
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  Each of these forms can be further classified into forms associated or not 
associated with pericranial tenderness 
ICHD -2 DIAGNOSTIC CRITERIA FOR TENSION TYPE 
HEADACHE        
A. Atleast 10 episodes fulfilling criteria B-E; headache < 1 day / month 
(episodic infrequent) , 1-14 days / month (episodic frequent) , or ≥ 15 
days / month for  > 3 months ( chronic). 
B. Headache lasting from 30 min to 7 days  
C. Atleast two of the following pain characteristics 
1. Pressing or tightening (non- pulsating) quality 
2. Mild or moderate intensity 
3. Bilateral location. 
4. No aggravation by walking stairs or similar routine physical 
activity  
D. Both of the following 
o Neither moderate or severe  nausea nor vomiting. 
o Photophobia or phonophobia are absent, or one but not the other 
may  be present 
E. Not attributed to another disorder 
       2.X.1. Associated with pericranial tenderness 42 
A. Fulfills criteria for 2.X 
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  B. Increased tenderness on pericranial manual palpation 
2.X.2. Not associated with pericranial tenderness 
 A. Fulfills criteria for 2.X 
 B. Not associated with pericranial tenderness 
 XÆ replaced by corresponding digit of infrequent(1), frequent  
episodic (2), or chronic.13 
Management:- 
             A correct diagnosis should be assured by means of a headache diary 
recorded over at least 4 weeks. 
       The diary also may reveal triggers and medication overuse, and it 
establishes a baseline against which to measure the efficacy of treatments. 
 Significant comorbitities  (eg. anxiety or depression) should be 
identified and treated concomitantly. 
 Nonpharmacologic management should be considered for all patients 
who have TTH and is used widely. 43 
Non – pharmocological measures 
      Improvement of posture, relaxation, exercise programs, hot and 
cold packs, ultrasound, and electrical stimulation. Various techniques, such 
as massage, relaxation, and home-based exercises, and found a modest 
effect. 43, 44 
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     Psychologic treatment strategies have reasonable scientific support 
for effectiveness. Relaxation training is a self-regulation strategy that 
provides patients with the ability to consciously reduce muscle tension.45  
Pharmacological therapy:- 
 Acute pharmacologic therapy refers to the treatment of individual 
attacks of headache in patients who have episodic and chronic TTH drugs 
such as aspirin, acetaminophen, ibuprofen, naproxen sodium, Ketoprofen, 
diclofenac potassium. 43 
 The combination of analgesics with caffeine, codeine, sedatives, or 
tranquilizers frequently is used and increased efficacy when adding caffeine 
to aspirin or ibuprofen has been reported. 46 
 Prophylactic pharmacotherapy should be considered in patients who 
have chronic TTH who do not respond to nonpharmacologic treatment. Drug 
such as amitriptyline, maprotiline and mianserin, are reported as more 
effective.47 
MIXED TENSION MIGRAINE HEADACHE 
A mixed tension migraine is a chronic daily tension headache that 
occurs in addition to periodic migraine headaches. Some people get tension 
headaches daily in addition to occasional migraines. This is known as a 
mixed tension headache. It is very common to have both tension and 
migraine headaches. 48 
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The exact reason people get either of these headaches is not known. 
Stress, fatigue, anxiety, or depression generally cause tension headaches. 
Migraines are thought to be due to spasms of blood vessels inside the skull. 
Bright light, noise, tension, or certain things in the diet, such as alcohol or 
caffeine, often bring them on. There seems to be an inherited risk of 
migraines in many people. People who have both types of headaches usually 
have depression that contributes to the headaches. 48 
Treatment & Monitoring 
Treatment begins with a limitation on pain medications. This may cure 
the daily headaches completely. If this doesn't work, a person is usually 
started on other treatments. These may include behavioral and drug therapy. 
Stress-reduction methods may be effective. These methods include 
relaxation techniques, such as meditation. Biofeedback may also be useful. 
This involves the use of special machines to help a person reduce muscle 
tension. The machine may make a sound every time the muscles get tense, 
making someone aware of when they are getting tense. The person can then 
learn to reduce muscle tension, which makes the sound disappear. 
Eventually, people no longer need the machine to help them relax their 
muscles. 48 
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A headache diary or journal may help identify headache triggers. 
Counselling and therapy may also help a person deal with depression, 
tension, or anxiety. 
Medicines may be needed to treat depression. Other medicines may be 
given for the migraine headaches. Nonsteroidal anti-inflammatory drugs 
(NSAIDs), such as naproxen or ibuprofen, may be given for daily tension 
headaches. 
Long-term treatment involving medicine and behavior methods may 
be needed. The goal of treatment is to reduce the number and severity of 
headaches as much as possible. 48 
3.1 CLUSTER HEADACHE 
Previously used terms : 
 Ciliary neuralgia , erythromelalgia of the head, hemicrania 
neuralgiformis chronica , histaminic cephalagia , Horton’s headache , Harris 
– Horton’s disease , migrainous neuralgia , petrosal neuralgia. 13 
Description 
     Cluster headache is a form of intermittent, short lived, excruciating, 
unilateral head pain associated with autonomic dysfunction.  
Prevalence estimates range from 0.1% to 0.4%.49 for unknown reasons 
prevalence is 3- 4 times higher in men than in women. Recent evidence 
however suggests a progressively decreasing male preponderance. 50 Age of 
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onset is usually 20 -40 years. Cluster may be inherited (autosomal dominant) 
in about 5% of cases. 13 
Cluster headache is a severe , recurring , chronic disease . Attacks 
usually occurs in series (cluster periods) lasting for weeks or months 
separated by remission periods usually lasting months or years . However 
about 10 -15% of patients have chronic symptoms without remissions. 13 
The pain of cluster headache is described as sharp , stabbing, boring , 
drilling , piercing but generally not throbbing like migraine. The duration of 
pain is usually ranges from 15 to 180 minutes. During the  attack , patients 
find it difficult to lie down as it aggravates pain. 51 
Cluster headache is divided into two forms 
3.1.1 Episodic Cluster headache 
-The term episodic cluster headache indicates remission in between in 
between  attacks lasting for one month or more 
3.1.2 Chonic Cluster headache 13, 52 
3.1.2 CHRONIC CLUSTER HEADACHE 
Cluster headache attacks occurring for more than year without 
remission or with remissions lasting less than 1 month. 13 
The Chronic form of the disease can evolve from the episodic form 
(secondary chronic form), or it may develop de novo as  primary chronic 
cluster headache. Chronic Cluster headache occurs in approximately in 15% 
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of sufferers, is unremitting from onset (primary chronic cluster ) in 10%, and 
evolves from the episodic form in 5%. 13, 52 
  ICHD -2 DIAGNOSTIC CRITERIA FOR CHRONIC CLUSTER 
HEADACHE 
A. Atleast 5 attacks fulfilling criteria B-D 
B. Severe or very severe unilateral orbital, supraorbital and/or temporal pain 
lasting 15-180 minutes if untreated 
C. Headache is accompanied by atleast one of the following 
1. Ipsilateral conjuctival injection and or lacrimation 
2. Ipsilateral nasal congestion and/or rhinnorhoea] 
3. Ipsilateral eyelid oedema 
4. Ipsilateral forehead and facial sweating  
5. Ipsilateral miosis and/or ptosis 
6. A sense of restlessness or agitation 
D. Attacks have a frequency from one every other day to 8 per day 
E. Not attributed to another disorder  
F. Attacks recur over >  than 1 year without remission or with remissions 
lasting less than 1 month. 13, 52 
TREATMENT 
Cluster headache treatment can be divide into three classes. 
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Abortive Therapy 
1 Sumatriptan injection or nasal spray (>90% effective) 
2 Oxygen 
3 Dihydroergotamine 
4 Ergotamine 
5 Zolmitriptan  
6 Intranasal lidocaine 
7 Greater occipital nerve  blockade 
Transitional therapy 
1. Corticosteroids 
2. Naratriptan 
3. Dihydroergotamine 
4. Occipital nerve blockade 
Preventive therapy 
1. Verapamil 
2. Lithium carbonate 
3. Divalproex sodium 
4. Topiramate 
5. Melatonin53 
Surgical Treatment of Cluster Headache 
 Surgical treatment of cluster headache should only be considered after 
a patient has exhausted all medical options 
1. Surgery on the Cranial Parasympathetic System 
2. Surgery on the Sensory Trigeminal Nerve 
3. Radiofrequency thermocoagulation 
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New Strategies 
1. Hypothalamic stimulation 
2. Greater occipital nerve stimulation. 53 
4.8   NEW  DAILY  PERSISTENT HEADACHE 
NDPH , while not as common as chronic migraine or chronic tension 
type headache , is common enough to be part of the general neurologist’s 
practice. First described in 1986, it gained acceptance when it was placed 
within the Silberstein –Lipton criteria for CDH in 1994. The critical feature 
of the original description and subsequent S-L description was the onset : 
daily headache starts abruptly without a background of frequent or 
worsening headache. 54 
Previously used terms 
De novo chronic headache , chronic headache with acute onset. 
Description 
Daily or near-daily primary headache that begins without a history of 
evolution from episodic headache and then persists is traditionally classified 
as new daily persistent headache 
Headache that is daily and unremitting from very soon after onset 
(within 3 days at most). The pain is typically bilateral, pressing or tightening 
in quality and of mild to moderate intensity. There may be photophobia, 
phonophobia or mild nausea. 
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NDPH has been recognised by the second edition of IHS classification 
as a separate entity from chronic tension type headache. 13 
The prevalence of NDPH is approximately 0.1% of the general 
population.In speciality headache clinics , approximately  10% of patients 
who have Chronic daily headache meet the criteria for NDPH. NDPH has a 
female preponderance (2.5 :1) . Diagnosed at all ages , NDPH is usually 
begins in the second and third decade in women and fifth decade in men. 
Typically , patients are able to pin point the exact date  their headache 
started. In atleast half the cases , headache begins in relation to an infection 
or flu like illness or stressful life event. 55 
Pathophysiology  
 The Pathophysiology of NDPH is unknown. Because of the abrupt 
nature of onset and a reputation for being difficult to treat pharmacologically 
, secondary etiologies always need to be sought in a patient with suspected 
NDPH. Work up may include a gadolinium enhanced MRI and / magnetic 
resonance venography of the head and possibly spinal fluid analysis. 
 Proposed etiologies are heterogenous and have revolved around 
various associated infections ( Epstein Barr Virus , Salmonella, adenovirus , 
toxoplasmosis, varicella –zoster) although a minority of patients suffer a 
stressful life event prior to onset. The immune response to these infectious 
agents may induce an autoimmune cycle that maintains neurogenic 
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inflammation , but this is far from proven and upto 40% have no recognised 
trigger. 56 
Li and Rozen 2002 reported that 30% of 56 patients with NDPH 
started with an infection or flu like illness. 12% started after surgery , and 12 
% after a stressful life event. Whether lingering infection can be responsible 
for daily headaches lasting for months or years remains to be determined. In 
Li and Rozen’s series , 40 were men and 16 were women  , ranging in age 
from 12 to 78 years. The headache was bilateral in 64% , associated with 
nausea in 68% and associated with photophobia in 66%. 
MRI and CT scanning in 49 patients showed no significant abnormality. 57  
ICHD -2 DIAGNOSTIC CRITERIA FOR NEW DAILY PERSISTENT 
HEADACHE 
A. Headache for > 3 months fulfilling criteria B-D 
B. Headache is daily and unremitting from onset or from < 3 days from 
onset 
C. Atleast two of the following pain characteristics: 
1. Bilateral location 
2. Pressing/tightening ( non-pulsating ) quality 
3. Mild or moderate intensity 
4. Not aggravated by routine physical activity such as walking or 
climbing stairs 
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D. Both of the following 
1. No more than one of photophobia, phonophobia or mild nausea 
2. Neither moderate or severe nausea nor vomiting 
E. Not attributed to another disorder. 13 
Management 
NDPH is difficult to manage. These patients commonly receive 
preventive medications used to treat migraine such as beta blockers, 
topiramate, valproic acid , or gabapentin , with very low efficacy. Tricyclics 
, SSRI and muscle relaxants are usually inefficacious . 55 
SECONDARY HEADACHES 
5 HEAD ATTRIBUTED TO HEAD AND / OR NECK TRAUMA 
Post Traumatic Headache:- 
Headache as a result of head trauma are one of the most common 
secondary headaches. Headaches are estimated as occurring variably in 30 to 
90% of persons who are symptomatic after mild head injury. 58 
According to the IHS, the onset of the headache should be less than 7 
days after the injury. 13,58 
Epidemiology 
        The annual incidence of head trauma is about 200/100000  people in the 
united states but more than double that number in other parts of the world. 
59,60 75% of the cases of brain trauma are classified as mild  and the annual 
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incidence ranges from approximately 100 to 500 per 100000 people. In post-
traumatic headache tension type headache is the most common types. 
Moderate and severe injuries often cause structural lesions , example-  
cerebral laceration or intracranial hemorrhage. Microscopic changes are 
axonal degeneration or alteration in cerebral metabolism. 59 
 Pathophysiology and pathogenesis:- 
            Pain immediately following head trauma may be generated via pain 
nerve terminals in stretched or otherwise traumatized muscles, ligaments, 
and cervical nerve roots, and perhaps from sympathetic nerve fibres on 
arteries accompanying cervical nerve roots. The convergence of nerve 
pathways from upper cervical roots and the spinal N of trigeminal nerve in 
the upper brainstem explains pain radiation from the neck to the frontal areas 
of the head and vice-versa.The evolution of acute post-traumatic headache to 
the chronic form may be associated with central pain sensitization. 59, 61 
              Regional cerebral blood flow studies (rCBF) have shown abnormal 
asymmetrical rCBF and focal zones of decreased perfusion in people with 
chronic traumatic headache. In PET scan metabolic rate of glucose 
utilisation was decreased. 59, 62 
Clinical features:- 
   Post concussion syndrome:- 
1) Trigger an attack of migraine with aura. 
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2) Blurred vision, photophobia, tinnitus. 
3) Depression , anxiety and personality changes are common. 63 
4) Apathy, insomnia and impaired libido. 
5) Forgetfulness & learning difficulties. 59 
Diagnostic  Criteria for Chronic post traumatic headache attributable to 
mild head injury 
A. Headche , no typical characteristics known, fulfilling criteria C and D 
B. Head trauma with all the following: 
C. Headache develops within 7 days after head trauma. 
1. Either no loss of consciousness, or loss of consciousness of < 30 
min duration 
2. Glasgow coma scale > 13 
3. Symptoms and/or signs diagnostic of concussion. 
D. Headache persists for >3 months after head trauma13, 59 
Diagnostic  Criteria for Chronic post traumatic headache attributable to 
moderate head injury 
Criteria:- 
 A    Headache, no typical characteristics  known, fulfilling criteria C and D 
B. Head trauma with at least one of the following: 
1. loss of consciousness for > 30 min traumatic brain lesions 
2. Glasgow scale <13 
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3. Post-traumatic amnesia >48 hours 
4. Imaging demonstration of a traumatic brain lesion 
C. Headache develops with in 7 days after head trauma or after regaining  
 consciousness following head trauma. 
D. Headache persists for > 3 months after head trauma13, 59 
Treatment:- 
      Tricyclic antidepressants, Antiepileptic ( divalproex, gabapentin). 
      Lifestyle modifications:- 
       Exercise and relaxation  
  Diet and avoidance of other headache triggers. 
      Other used therapies:- 
       Biofeedback, Physical therapy ( massage, heat,cold) , acupuncture. 
       Transcutaneous electrical stimulation. 
       Trigger point injections and nerve blocks. 59 
6 HEADACHE ATTRIBUTED TO CRANIAL OR CERVICAL 
VASCULAR DISORDERS 
Headache attributed to ischemic stroke:- 
 Headache accompanies ischemic stroke in 17 – 34% of cases; it is 
more frequent in basilar than in carotid –territory strokes. 
 The headache of ischemic stroke is accompanied by focal neurological 
signs and/ or alterations in consciousness usually allowing easy 
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differentiation from the primary headaches. It is usually of moderate 
intensity and no specific characteristics.13 
 With cerebral infarction , headache tends to be more common with 
stroke in areas supplied by the posterior circulation . when present the 
headache tends to be non pulsatile and ipsilateral to the involved hemisphere. 
Pathophysiology:- 
1. Dilatation of collaterals supplying the ischemic region 
2. Distension of occluded parent vessel . 
3. Ischemia of arterial muscle 
4. Acute Hypertension 
5. Stroke- associated edema 
6. Platelet aggregation & release of serotonin, alteration in 
neurotransmitter. 64,65 
Diagnostic Criteria:- 
A. Any new headache fulfilling criteria C 
B. Neurological signs and/or neuroimaging evidence of a recent 
ischemic stroke 
C. Headache develops simultaneously with or in very temporal 
relation to signs or other evidence of ischemic stroke. 13 
Treatment:- 
   Analgesics & Supportive management. 
7 HEADACHE ATTRIBUTED TO NON VASCULAR 
INTRACRANIAL DISORDER 
7.1.1 Idiopathic intracranial hypertension  
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Previously used terms 
Benign intracranial hypertension ,  Pseudotumour cerebri , Meningeal 
hydrops , Serous meningitis. 13 
Description 
The term pseudotumor cerebri was coined by Nonne in 1914 and has 
remained a useful means of designating a common and highly characteristic 
syndrome of headache, papilledema (unilateral or bilateral), minimal or 
absent focal neurologic signs, and normal CSF composition, all occurring in 
the absence of enlarged ventricles or an intracranial mass on CT scan or 
MRI. 
Pathophysiology   
The mechanism of increased CSF pressure in the above-described 
idiopathic form of the disorder has remained elusive, but recent experience is 
converging on the possibility that there is a functional obstruction to outflow 
in the venous sinuses. Karahalios and colleagues and others have found the 
cerebral venous pressure to be consistently elevated in pseudotumor cerebri; 
in half of their patients, there was a venous outflow obstruction demonstrated 
by venography, often with a pressure gradient across the site. 
Symptomatic Causes of Pseudotumor Cerebri  
The main considerations in cases of generalized elevation of ICP and 
papilledema in the absence of an intracerebral mass are covert occlusion of 
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the dural venous sinuses, gliomatosis cerebri, occult arteriovenous 
malformation, and carcinomatous, infectious, or granulomatous meningitis. 
In addition to mechanical factors, a number of toxic and metabolic 
disturbances may give rise to a pseudotumor syndrome. In children, as 
chronic corticosteroid therapy is withdrawn, there may be a period of 
headache, papilledema, and elevated ICP with little or no enlargement of the 
lateral ventricles. Lead toxicity in children may be marked by brain swelling 
and papilledema. Excessive doses of tetracycline and vitamin A (particularly 
in the form of isotretinoin, an oral vitamin A derivative used in the treatment 
of severe acne) have also been shown to cause intracranial hypertension in 
children and adolescents. 66 
Diagnostic criteria : 
A.Progressive headache with atleast one of the following characteristiiteria  
and fulfilling criteria C and D 
  1. Daily occurrence 
  2. Diffuse and / or constant (non- pulsating) pain 
  3. Aggravated by coughing or straining 
B.Intracranial hypertension fulfilling the following criteria 
   1.  Alert patient with neurological examination that is either normal  
        or  demonstration of any of the following abnormalities: 
a) Papilledema 
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b) Enlarged blind spot 
c) Visual field defect 
d) Sixth nerve palsy.   
2. Increased CSF pressure 
3. Normal CSF chemistry and cellularity 
4. Intracranial diseases ruled out by appropriate investigations 
5. No metabolic, toxic or hormonal cause of intracranial 
hypertension. 
C.  Headache develops in close relation to increased intracranial pressure. 
D.  Headache improves after withdrawal of CSF to reduce pressure to 120-  
     170mm H2O and resolves within 72 hours of persistent normalisation of  
    intracranial pressure. 13 
Treatment 
Medical Management 
• Diet and weight loss 
• Diuretics(Acetozolamide , frusemide) 67,68 
• Corticosteroids69 
• Tricyclic antidepressants 
• Sodium valproate 
 
Surgical treatment 
• Optic nerve sheath decompression70 
• CSF shunting67 
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7.4 HEADACHE ATTRIBUTED TO INTRACRANIAL NEOPLASM 
Headache is said to be a significant symptom in about two-thirds of all 
patients with brain tumor, but it is infrequent , particularly as the heralding 
symptom of a tumor in an adult. 
The pain has no specific features; it tends to be deep-seated, usually 
non throbbing (occasionally throbbing), and is described as aching or 
bursting. Attacks of pain last a few minutes to an hour or more and occur 
once or many times during the day. Physical activity and changes in position 
of the head may provoke pain, whereas rest diminishes its frequency. 
Nocturnal awakening because of pain occurs in only a small proportion of 
patients and is by no means diagnostic. Unexpected forceful (projectile) 
vomiting may punctuate the illness in its later stages. If unilateral, the 
headache is nearly always on the same side as the tumor. 71   
Diagnostic Criteria:- 
A. Headache with at least one of the following characteristics and 
fulfilling criteria C and D 
 Progressive 
 Localised 
 Worse in the morning 
 Aggravated by coughing or bending forwards. 
B. Intracranial neoplasm shown by imaging 
C. Headache develops in temporal relation to the neoplasm 
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D. Headache resolves within 7 days after surgical removal or volume 
reduction of neoplasm or treatment with corticosteroids. 13 
Treatment:- 
          Treatment depends on the type of tumor, patient functional status and 
stage of disease. Patients who have metastatic brain tumors have a limited 
life expectancy and treatment is palliative. Corticosteroids such as 
dexamethasone often provide dramatic relief of headache and other 
symptoms caused by cerebral edema,.72 
         Whole brain radiotherapy often effectively controls symptoms. 73 In 
selected patients surgical resection or stereotactic radiosurgery may provide 
more durable symptom control. 74 High-grade gliomas are the most common 
primary brain tumors and definitive  treatment with surgery and radiotherapy 
usually results in headache remission. 72  
8 HEADACHE ATTRIBUTED TO ITS SUBSTANCE OR ITS 
WITHDRAWAL  
8.2 MEDICATION OVERUSE HEADACHE 
 Headaches can be an effect of acute or chronic medication exposure 
or be caused by withdrawal from a substance.  
A headache is attributed to a substance if a new kind of headache 
occurs for the first time in close temporal relation to exposure to the 
substance, regardless of the characteristics of the headache  , even it 
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resembles a primary headache such as migraine , tension-type headache or 
cluster headache. 75 
 Patients who have frequent headaches often overuse analgesics,  
opiods, ergotamine , or triptans. This medication overuse can produce 
chronic daily headache (CDH)( Drug- induced rebound headache  ) , which 
is accompanied by dependence on symptomatic medication and 
refractoriness to prophylactic medication. 75,76,77  Stopping the symptomatic 
medication may result in withdrawal symptoms , a period of increased 
headache and then improvement. 78 
The diagnosis of medication overuse headache is extremely important 
clinically because patients usually do not respond to preventive medications 
while overusing drugs. 75 
The new IHS classification has several types of medication overuse 
headache: 
 Ergotamine overuse headache, Opiod overuse headache, Combination 
drug medication overuse headache , other substance overuse headache , and 
headache as a side effect of drugs used for other indication. 13,75 
Criteria for medication overuse headache 
At least one of the following for at least one month 
A. Simple analgesic use ( > 1000 mg ASA/ acetaminophen) > 5 d/week 
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B. Combination analgesics  ( caffeine, barbituarate)  (>3 tablets/day) > 3 
d/wk 
C.  Opiods( >1 tablet/day) > 2d/wk 
D. Ergotamine use (1mg po or 0.5 mg pr) > 2 days/wk. 
Diagnostic criteria for Analgesic overuse headache. 
A. Headache present on >15 days/month with at least one of the 
following characteristics and fulfilling criteria C and D. 
• Bilateral 
• Pressing/ tightening( non-pulsating) quality 
• Mild or moderate intensity. 
B. Intake of simple analgesics on > 15 days/month for > 3 months 
C. Headache has developed or markedly worsened during analgesic overuse 
D. Headache resolves or reverts to its previous patterns within 2 months 
after discontinuation of analgesics13 
Treatment:- 
  Pharmacological:- 
 Outpatient Management:- 
1) Substitute a long acting NSAID and taper the overused medication 
2) Abruptly discontinuing the overused headache and substitute    
        transitional medicine such as NSAID, DHE, or corticosteroid.   
Inpatient Management:- 
1 Detoxification 
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2 Rehydration 
3 Pain control with parenteral therapy 
4 Establishing effective prophylaxis 
5 Interrupting the cycle of pain 
6 Patient education 
7 Establishing  outpatients  methods of pain control. 75,79 
Diet and lifestyle changes. 
Physical therapy and exercise. 75                                          
11 HEADACHE OR FACIAL ATTRIBUTED TO DISORDER OF 
CRANIUM , NECK ,EYES , EARS , NOSE , MOUTH , SINUSES ,  
TEETH, MOUTH , OR OTHER FACIAL OR CRANIAL 
STRUCTURES 
11.8 POST SINUSITIS HEADACHE:- 
Sinusitis is over diagnosed as a cause of headache because of the 
belief that pain over the sinuses must be related to the sinuses. In fact frontal 
headache is usually caused by migraine or tension headache. If patients does 
not respond to treatment for migraine and tension headache one should 
reconsider the diagnosis of sinus disease. 
Diagnostic Criteria:- 
A. Pain in one or more regions of the head, face, ears or teeth. 
B. Clinical, laboratory, or imaging evidence of an acute rhinosinusitis 
C. Simultaneous onset of headache and rhinosinusitis 
D. Headache lasts < 7 days after  
E. Remission or successful treatment of acute rhinosinusitis. 80 
Factors associated:- 
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Major factors 
  Facial pain/ pressure 
      Facial congestion/ fullness 
    Nasal obstruction/blockage 
    Nasal discharge 
    Hyposmia/anosmia 
    Fever ( acute rhinosinusitis) 
         Purulence in nasal cavity on examination. 
Minor Factors 
¾ Headache 
¾ Fever 
¾ Halitosis 
¾ Fatigue 
¾ Dental pain 
¾ Cough 
¾ Ear pain/ pressure/  fullness.    
Diagnostic Criteria:-  > 2 major factors, or 1 major factor and 2 minor  
factors, or nasal  purulence on examination. 
Probable:-  1 major factor or >2 minor factor. 81 
Investigations:- 
Anterior Rhinoscopy  
CT-PNS 82 
Diagnostic fiberoptic endoscopy. 
Treatment:- 
Treat the bacterial infection by broad spectrum antibiotic. 
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Reduce ostial swelling by Nasal decongestants. 
Drain the sinuses. 
Maintain sinus ostia patency – Corticosteroids. 81 
12 HEADACHE ATTRIBUTED TO PSYCHIATRIC DISORDER 
The most common cause of generalized persistent headache, both in 
adolescents and adults, is depression or anxiety in one of its several forms. 
The authors have also noted that many seriously ill psychiatric patients 
complain of frequent headaches that are not typically of the tension type. 
These patients report unilateral or generalized throbbing cephalic pain 
lasting for hours every day or two. The nature of these headaches, which in 
some instances resemble common migraine, is unsettled. Others have 
delusional symptoms involving physical distortion of cranial structures. As 
the psychiatric symptoms subside, the headaches usually disappear. 
Odd cephalic pains, e.g., a sensation of having a nail driven into the 
head (clavus hystericus), may occur in hysteria and raise perplexing 
problems in diagnosis. The bizarre character of these pains, their persistence 
in the face of every known therapy, the absence of other signs of disease, and 
the presence of other manifestations of hysteria provide the basis for correct 
diagnosis. Older children and adolescents sometimes have peculiar 
behavioral reactions to headache: screaming, looking dazed, and clutching 
the head with an agonized look. Usually, migraine is the underlying disorder, 
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the additional manifestations responding to therapeutic support and 
suggestion. 71 
Diagnostic Criteria:- 
A Headache , no typical characteristics known , fulfilling criterion C 
B Presence of somatisation disorder fulfilling DSM IV criteria 
1 History of many physical complaints beginning before age 30 that 
occur over a period of several years and result in  treatment being 
sought and/or significant impairment in social, occupational or other 
important areas of functioning 
    2    At least four pain symptoms , two non-pain gastrointestinal symptoms, 
one sexual or reproductive symptom and one pseudo neurological symptom 
  3     After investigations symptoms  cannot be fully explained by a general 
medical condition  
   C    Headache not attributable to another cause. 13 
Treatment:- 
 Behavioural therapy 
 Treating underlying psychiatric disorder. 71 
13 CRANIAL NEURALGIAS AND CENTRAL CAUSES OF FACIAL 
PAIN. 
13.1 TRIGEMINAL NEURALGIA 
Trigeminal neuralgia is a distinct , painful disorder of the face that 
easily is evoked by trivial stimuli and undergoes a relapsing , remitting 
course. 83 
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This is a common disorder of middle age and later life, consisting of 
paroxysms of intense, stabbing pain in the distribution of the mandibular and 
maxillary divisions (rarely the ophthalmic division) of the fifth cranial nerve. 
The pain seldom lasts more than a few seconds or a minute or two, but it 
may be so intense that the patient winces involuntarily; hence the term tic. It 
is uncertain whether the tic is reflexive or quasi-voluntary. The paroxysms 
recur frequently, both day and night, for several weeks at a time.  
Another characteristic feature is the initiation of a jab or a series of 
jabs of pain by stimulation of certain areas of the face, lips, or gums, as in 
shaving or brushing the teeth, or by movement of these parts in chewing, 
talking, or yawning, or even by a breeze—the so-called  trigger zones. 71 
Diagnostic Criteria: 
1) Paroxysmal attacks affecting one or more divisions of the trigeminal 
nerve,lasting for a few seconds to less than two minutes. 
2)  Pain has at least one of  the  following   characteristics: intense , 
sharp, superficial, stabbing, and precipitated from trigger areas or by 
trigger factors 
3) There is no clinically evident neurological deficit 
4) Attacks are stereotyped in the individual patient. 
5) Not attributed to another  disorder 
6) Headache lasts < 3 months after successful treatment of the causative 
disorder.13 
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Treatment  
Anticonvulsant drugs such as phenytoin (300 to 400 mg/day), valproic 
acid (800 to 1200 mg/day), clonazepam (2 to 6 mg/day), gabapentin (300 to 
900 mg/ day), and particularly carbamazepine (600 to 1200 mg/day), alone 
or in combination, suppress or shorten the duration and severity of the 
attacks. Carbamazepine is effective in 70 to 80 percent of patients, but half 
become tolerant over a period of several years.  
Baclofen may be useful in patients who cannot tolerate carbamazepine 
or gabapentin, but it is most effective as an adjunct to one of the 
anticonvulsant drugs. Capsaicin applied locally to the trigger zones or the 
topical instillation in the eye of an anaesthetic (proparacaine 0.5%) has been 
helpful in some patients.  
Most of the patients with intractable pain come to surgery or an 
equivalent form of root destruction. The commonly used procedures are  
1) Stereotactically controlled thermocoagulation of the trigeminal roots 
using a radiofrequency generator  or similarly applied focused gamma 
radiation and 
2)  The procedure of vascular decompression, popularized by Jannetta, 
which requires a posterior fossa craniotomy but leaves no sensory 
loss. Gamma knife radiation is emerging as a less intrusive alternative, 
but its full effect is not evident for many months. In practice, an 
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anticonvulsant is often required for some period of time even after any 
of these procedures, and it must be reinstituted when symptoms 
reoccur, as they often do in our experience. 71 
HEADACHE AND RADIOLOGY 
Headaches are one of the most common symptoms that neurologists 
evaluate.  Although most are caused by primary disorders, the list of 
differential diagnoses is one of the longest, with over 300 different types and 
causes. The cause or type of most headaches can be determined by a careful 
history supplemented by a general and neurologic examination. Reasons for 
obtaining neuroimaging include medical indications as well as anxiety of 
patients, families and medico-legal concerns. 
COMPUTED TOMOGRAPHY  AND MAGNETIC RESONANCE 
IMAGING 
At present the two most widely used imaging modalities in neuro 
radiology are CT scan & MRI.  CT is used as the  primary imaging 
modality in any case of headache. If diagnostic dilemma remains or if any 
surgical treatment is anticipated MRI & other imaging modalities can be 
used.    
CT is better than MRI in detecting calcification in certain lesions like 
certain tumors, granuloma & parasites. It is also very useful for those 
patients who cannot tolerate or have contraindications to MRI scanning as in 
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cases of claustrophobia patients, with metallic bone prosthesis, Intracranial 
aneurysm clips, pacemakers etc. CT is comparatively cheap and is available 
in most of tertiary care centre. 
The preferred CT technique in Headache is without contrast medium 
although the latter may be given if initial images suggests an alternative 
diagnosis. Ideally all patients should be scanned in the first instance with out 
IV contrast medium so that the decision as to whether contrast medium 
should be used is based on the clinical & imaging finding in each case. 
As routine outpatient neuroimaging became available more than 20 
years ago, controversy arose over appropriate selection of patients for 
computed tomography studies and subsequently magnetic resonance imaging 
studies. Nowhere is this more apparent than in headache. Because headache 
is a truly ubiquitous condition with a lifetime prevalence rate reaching 90%, 
it is clear that it is not possible to scan all patients with headache.  
However, patients with new-onset headaches, headaches with a 
progressive course, headaches with a significant change in pattern, 
headaches that never alternate sides, and headaches associated with any 
neurologic findings or seizures have a substantially higher likelihood of a 
secondary cause such as tumor, arteriovenous malformation, or other 
structural lesion. In these situations, imaging must be considered as part of 
the workup.  
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Combining the results of multiple studies performed reveal the overall 
percentages of various pathologies as: brain tumors, 0.8%; arteriovenous 
malformations, 0.2%; hydrocephalus, 0.3%; aneurysm, 0.1%; subdural 
hematoma, 0.2%; and strokes, including chronic ischemic processes, 1.2%  
EEG is not useful in the routine evaluation  
 When new-onset headaches begin in patients over the age of 50 years, 
the physician always should consider whether it may be a secondary 
headache disorder requiring specific diagnostic testing and treatment. Up to 
15% of patients 65 years and over who present to neurologists with new-
onset headaches may have serious pathology such as stroke, TIA, neoplasm, 
and subdural hematoma. 
DIFFUSION-PERFUSION  IMAGING 
           White matter abnormalities have been reported on MRI 354 SB Desai 
studies of patients with all types of migraine, ranging from 12% to 46%. The 
cause of white matter bnormalities in migraine is not certain. Cerebral 
atrophy has been reported as more frequent and no more frequent in patients 
with migraine compared to controls. It has been found that during acute 
episodes one might have focal areas of ischemia detected by combination of 
diffusion & perfusion imaging which reverse with time. They may also have 
small infarcts at the gray-white matter junction. 84 
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MATERIALS  AND  METHODS 
  STUDY PERIOD 
       This is an observational study undertaken over period of  MAY 2009-
APRIL-2010 
 STUDY PLACE 
This study was carried out at the Neurology outpatient department, 
Govt. Royapettah hospital,Chennai. 
ETHICAL CONSIDERATIONS 
 The study was reviewed and approved by the Institutional Ethical 
Committee, Kipauk Medical College and General Hospital, Chennai. 
STATISTICAL ANALYSIS 
 Statistical analysis were carried out using statistical package for Social 
sciences and Epi- software by statistician . 
 STUDY POPULATION 
            Observational  study which included patients attending neurology 
outpatient   department with complaints of headache for more than three 
months. 
INCLUSION CRITERIA 
1) Patients with complaints of Headache for > 3 months. 
2) Patients above 12 years of age group. 
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EXCLUSION CRITERIA 
Pregnant mothers were excluded from the study. 
 
100 patients were included in the study after getting written informed 
consent. 
 
Detailed history was obtained from all patient .The questionnaire 
recorded the occupation , frequency , intensity, duration , laterality , 
character of pain, associated symptoms , aggravating factors and family 
history.  
 
Detailed examination with reference to general condition, refractory 
error  , fundus examination , neck movements and CNS examination. 
 
Specialist opinion in ENT, Ophthalmology and Psychiatry was 
obtained for all the patients. 
 
All patients of chronic headache were followed up with either 
CT/MRI after detailed questionnaire to rule out the secondary headache. 
 
 International Classification of  Headache Disorder II  criteria applied 
to classify headache. 
 
 
 
60 
 
RESULTS 
This  study was carried out during the period May 2009 to April 2010 
in the Department of Neurology, Govt. Royapettah hospital, Chennai . A 
total of 100 patients were registered in the neurology clinics.   
TABLE - 1 
DISTRIBUTION OF PATIENTS WITH CHRONIC PRIMARY AND 
CHRONIC SECONDARY HEADACHE (n=100) 
 
Type of Chronic Headache Number of patients 
 
Percentage 
 
Chronic Primary headache 82 82 
Chronic Secondary headache 18 18 
Total 100 100 
 
 
 Chronic Primary headache is the most common type accounting for 
82%. 
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TABLE -2 
DISTRIBUTION OF DIFFERENT TYPES OF CHRONIC 
HEADACHE AMONG THE  TARGET POPULATION  (n = 100) 
 
Types of chronic headache No. of Patients 
 
Percentage 
Chronic Migraine headache 42 42 
Chronic Tension  headache 23 23 
Probable  Chronic Migraine 04 04 
Episodic Migraine With aura 
transition to  chronic migraine 
03 03 
New daily persistent headache 05 05 
Chronic Cluster headache 01 01 
Mixed Headache (Tension + 
Migraine) 
04 04 
Drug overuse headache 05 05 
Post sinusitis headache 05 05 
Trigeminal neuralgia 03 03 
Post traumatic headache 02 02 
Psychogenic headache 01 01 
SOL Right Cerebral Hemisphere 01 01 
Benign intracranial hypertension 01 01 
Total 100 100 
 
 Chronic Migraine headache is the most common type of chronic 
headache  accounting for 42% 
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TABLE -3 
DISTRIBUTION OF  PATIENTS WITH DIFFERENT TYPES OF 
CHRONIC PRIMARY HEADACHES (n = 82) 
 
Types of Primary 
headache 
ICHD type No of 
Patients 
Percentage 
 
Migraine and its variants 1 49 60 
Chronic Tension headache 2.3 23 28 
New daily persistent 
headache 4.8 5 06 
Chronic Cluster headache 3.1.1 1 01 
Mixed(Tension+migraine) - 4 5 
Total - 82 100 
 
  Migraine headache is the most common primary headache disorder 
seen in 49 patients (60% ) followed  by Chronic tension type seen in 23 
patients (28%). 
 
TABLE – 4 
TYPES OF MIGRAINE HEADACHE 
 
 
Types of  Migraine headache No. of Patients Percentage 
 
 Chronic migraine 42 85 
 Episodic migraine with aura transition 
to chronic migraine 03 07 
 Probable Chronic Migraine 04 08 
Total 49 100 
  
Among the 49 patients with migrainous headache , 42 patients (85%) 
presented with Chronic migraine followed by 4 patients (8%) with probable 
chronic migraine and the remaining 3 patients had transition from migraine 
with aura to chronic migraine. 
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TABLE -5 
DISTRIBUTION OF CHRONIC TENSION TYPE   HEADACHES 
 
Type of CTTH ICHD-2 type No of 
patients 
Percentage 
CTTH with Pericranial tenderness 2.3.1 02 09
CTTH without Pericranial 
tenderness 2.3.2 21 91 
Total - 23 100 
 
 Of the 23  patients with CTTH, 2 patients  presented with pericranial 
tenderness accounting for 9%.  
 
TABLE -6 
DISTRIBUTION OF PATIENTS WITH DIFFERENT TYPES OF 
SECONDARY HEADACHE   (n = 18) 
 
Types of Secondary headache  No of 
Patients 
Percentage 
Benign intracranial hypertension 01 06 
Drug overuse headache 05 28 
Post sinusitis headache 05 28 
Post traumatic headache 02 11 
Psychogenic headache 01 06 
SOL Right Cerebral Hemisphere 01 06 
Trigeminal neuralgia 03 17 
Total 18 100 
  Post sinusitis headache and drug overuse headache were more 
common among the patients with secondary headache. 
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TABLE 7 
SEX DISTRIBUTION OF PATIENTS WITH CHRONIC HEADACHE  
Sex No. of patients 
 
Percentage 
Female 66 66 % 
Male 34 34% 
Total  100 100 
 
Females outnumbered males accounting for 66% of the target 
population 
 
TABLE 7A 
SEX DISTRIBUTION OF PATIENTS WITH PRIMARY AND 
SECONDARY HEADACHE 
 
Sex  Primary Headache 
          n = 82  
Secondary  Headache 
  
    n = 18 
No. of 
Patients 
% 
 
No. of Patients % 
Male 28 
 34 06 33 
Female 54 
 66 12 67 
 
There was a female predominance among the patients with primary as 
well as secondary headache. There was no significant difference in the 
gender distribution among primary and secondary headache patients. 
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TABLE 7B 
SEX DISTRIBUTION OF PATIENTS WITH PATIENTS WITH 
PRIMARY HEADACHE 
 
 
  Sex 
 
Migraine 
headache 
n = 49 
 
Tension 
headache 
n = 23 
NDPH 
n = 5 
Mixed 
headache 
n = 4 
No. of 
Patients 
% No. of 
Patients 
% No. of 
Patients 
% No. of 
Patients 
% 
Male 
 14 29 08 35 03 60 03 75 
Female 
 35 71 15 65 02 40 01 25 
 
Majority of the patients with migraine and tension type headache were 
females accounting for 71% and 65% respectively . 
TABLE 8 
AGE DISTRIBUTION IN PATIENTS WITH CHRONIC HEADACHE 
Age 
(in 
years) 
   Migraine 
      n = 49 
Tension 
headache 
 n = 23 
     NDPH   
       n =5 
Mixed 
headache 
n = 4 
Secondary 
   n = 18  
No. of 
patients 
% No. of 
patients 
% No. of 
patients 
% No. of 
patients 
% No. of 
patients
% 
13-20 09 19 03 13 00 00 02 50 02 11 
21-30 15 31 09 39 02 40 02 50 08 44 
31-40 14 28 08 35 01 20 00 00 03 17 
41-50 08 16 03 13 02 40 00 00 02 11 
> 51 03 06 00 00 00 00 00 00 03 17 
Majority of the chronic headache patients were in the age group of 21-
40 years. There was no significant difference in the age group distribution 
among the patients with different types of chronic headache. 
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TABLE -9 
DISTRIBUTION OF HEADACHE CHARACTER 
Headache  
character 
Migraine 
n = 49 
Chronic 
Tension 
n = 23 
NDPH 
n =5 
Mixed 
headache 
n = 4 
No. of 
patients 
% No. of 
patients 
% No. of 
patients 
% No. of 
patients 
% 
Pulsating /  
 Throbbing 
49 100 0 0 0 0 02 50 
Pressing 0 0 22 96 05 100 01 25 
Others 0 0 01 04 0 0 01 25 
 
            Majority of the Migraine headache retains its pulsatile /throbbing  
quality whereas  majority of patients with tension and NDPH  had headache 
of pressing quality.   
 
TABLE -10 
INTENSITY OF HEADACHE AMONG PATIENTS WITH CHRONIC 
HEADACHE 
 
Headache 
Intensity 
Migraine 
 
N = 49 
Chronic 
Tension 
n = 23 
NDPH 
n =5 
Mixed 
headache 
n = 4 
Secondary 
n = 18 
No. of 
patients 
% No. of 
patients
% No. of 
patients
% No. of 
patients 
% No. of 
patients
% 
Moderate 
 01 2% 16 69% 05 100% 01 25% 10 56%
Severe 
 
48 
 98% 07 31% 00 0% 03 75% 08 44%
 
Intensity of headache was more severe in majority of patients with 
migraine (98%) and mixed type of headache (75%). Majority of tension 
type, NDPH and secondary headache presented with headache of moderate 
intensity. 
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TABLE -11 
DISTRIBUTION OF  SITE OF PAIN IN CHRONIC HEADACHE 
PATIENTS 
 
Among the migraine patients, 51% presented with bilateral headache 
and the remaining 49% with unilateral headache. Majority of patients with 
tension headache, NDPH and mixed headache presented with bilateral 
headache accounting for 91%, 100% and 100% respectively. Of the 18 
patients with secondary headache, 78% presented with bilateral pain and the 
remaining 22% with unilateral location. 
 
TABLE 12 
DISTRIBUTION OF LOCATION OF HEADACHE IN PATIENTS 
WITH CHRONIC HEADACHE 
 
 
Headache   
location 
Migraine 
n = 49 
Chronic 
Tension 
n = 23 
NDPH 
n =5 
Mixed 
headache 
n = 4 
No. of 
patients 
% No. of 
patients
% No. of 
patients
% No. of 
patients 
% 
Frontal 9 18 2 8 0 0 1 25 
Frontotemporal 27 55 16 70 3 60 1 25
Frontooccipital 6 12 2 9 1 20 0 0
Occipital 7 14 1 4 1 20 1 25 
Temporal 0 0 0 0 0 0 0 0
Temporoparietal 0 0 2 9 0 0 1 25 
 
        Fronto temporal area is the most common site . Other common 
locations are frontal and occipital. Least common is temporal side. 
 
Site of 
Pain 
Migraine 
 
n = 49 
Chronic 
Tension 
n = 23 
NDPH 
 
n =5 
Mixed 
headache 
n = 4 
Secondary 
 
n = 18 
No. of 
patients 
% No. of 
patients
% No. of 
patients 
% No. of 
patients 
% No. of 
patients
% 
Unilateral 24 49 02 9 0 0 0 0 4 22 
Bilateral 25 51 21 91 05 100 4 100 14 78
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TABLE -13 
DISTRIBUTION OF NUMBER OF HEADACHE DAYS/MONTH IN 
PATIENTS WITH DIFFERENT TYPES OF CHRONIC HEADACHE 
 
Majority of chronic headache patients suffers from headache around  
15-25 days / month. However in NDPH  patients had  headache through out 
the month.  
TABLE -14 
AGGRAVATING  FACTORS IN PATIENTS WITH CHRONIC 
HEADACHE 
 
 Stress is the most common aggravating factors in patients with chronic 
migraine (71%) as well as chronic tension headache (78%). Other 
aggravating factors such as noise, smell and lighting are commonly 
associated with migraine headache.  Cough and cold are the major 
aggravating factors in patients with post sinusitis headache (100%) whereas 
washing face, chewing acted as trigger factors for patients with Trigeminal 
neuralgia (100%) . 
No of days of 
Headache/month 
Migraine 
n = 49 
Chronic 
Tension 
n = 23 
NDPH 
n =5 
Mixed 
headache 
n = 4 
Secondary 
n = 18 
No. of 
patients 
% No. of 
patients
% No. of 
patients
% No. of 
patients 
% No. of 
patients
%
15-20 43 88 21 91 01 20 3 75 13 72
20-25 5 10 2 9 0 0 1 25 2 11
25-30 1 2 0 0 04 80 0 0 3 17
Aggravating 
factors 
Migraine 
n = 49 
Chronic 
Tension 
n = 23 
Post sinusitis     
headache 
n= 5 
Trigeminal 
neuralgia 
n = 3 
No. of 
patients 
% No. of 
patients
% No. of 
patients 
% No. of 
patients 
% 
Stress 35 71 18 78 0 0 0 0 
Noise 8 16 0 0 0 0 0 0
Smell 1 2 0 0 0 0 0 0
Lighting 7 14 0 0 0 0 0 0
Cough& cold 1 2 0 0 5 100 0 0 
Washing face 0 0 0 0 0 0 3 100 
Chewing 0 0 0 0 0 0 3 100 
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TABLE – 15 
ASSOCIATED SYMPTOMS IN CHRONIC HEADACHE PATIENTS 
ASSOCIATED 
SYMPTOMS 
Migraine Tension Cluster NDPH Mixed
Blurring of vision 23 11   2 
Photophobia 24 -  1 1 
Phonophobia 2 -    
Nausea 29 9  1  
Vomiting 28 5    
Rhinorrhea - - 1   
Lacrimation 2 - 1  1 
Dizziness - -    
         Predominant symptoms in migraine are nausea ,vomiting, photophobia, 
blurring of vision whereas tension headache has blurring of vision, nausea 
and vomiting in order of frequenc . 
 
TABLE:-16 
DURATION OF HEADACHE IN DIFFERENT TYPES OF  CHRONIC 
HEADACHE 
Duration of  
Headache in 
hours 
Migraine 
n = 49 
Chronic 
Tension 
n = 23 
NDPH 
n =5 
Mixed 
headache 
n = 4 
Secondary 
n = 18 
No. of 
patients 
% No. of 
patients
% No. of 
patients
% No. of 
patients 
% No. of 
patients
% 
4-8 31 63 19 83 1 20 1 25 11 61
9-16 2 4 1 4 0 0 0 0 1 12
17-24 11 22 3 13 3 60 3 75 5 15
>24  5 11 0 0 1 20 0 0 1 1 
 The most of the migraine and tension headache patients presented 
with headache for a duration of 4-8 hours . However majority of   NDPH and 
mixed headache persisted for 18-24 hours .  
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TABLE 17 
CT FINDINGS IN PATIENTS WITH PRIMARY HEADACHE 
CT  in  
Primary   
headache 
Migraine 
n = 49 
Chronic 
Tension 
n = 23 
NDPH 
n =5 
Mixed 
headache 
n = 4 
No. of 
patients 
% No. of 
patients
% No. of 
patients
% No. of 
patients 
% 
Normal  45 92 20 87 5 100 3 75 
Calcified 
granuloma 
 
2 4 0 0 0 0 0 0 
Calcification 1 2 2 9 0 0 1 25 
Infarct 1 2 0 0 0 0 0 0 
Age related 
atrophy 0 0 1 4 0 0 0 0 
 
     CT Brain of  majority of primary headache patients showed normal study. 
In few patients CT is associated with calcified granuloma which is 
insignificant. 
    
TABLE 18 
CT AND MRI IN PATIENTS WITH SECONDARY HEADACHE 
 
CT /  
MRI 
    
Image 
results 
 Post sinusitis  
      n= 5  
Post traumatic 
   n= 2 
Benign 
Intracranial 
hypertension 
N=1 
Space 
occupying 
lesion 
n=1 
No. of 
patients 
% No. of 
patients 
% No. of 
patients 
% No. of 
patients 
% 
CT 
BRAIN 
Normal  0 0 2 100 0 0 0 0 
SOL 0 0 0 0 0 0 1 100
CT PNS Maxillary 
sinusitis 5 100 0 0 0 0 0 0 
MRI 
BRAIN 
Prominent 
Optic N 0 0 0 0 1 100 0 0 
MRI Brain of the patient with benign intracranial hypertension 
revealed prominent optic nerve. CT Brain of the patients with chronic post 
traumatic headache was normal . 
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DISCUSSION 
In the present study, out of 100 patients with Chronic headache, 
primary headache was the predominant type accounting for 82% as 
compared to Secondary headache seen only in 18%. (Table – 1) This 
correlated well with the study done by  AP Jain et al 2007 in which majority 
of patients presented with primary headache accounting for 92.5% and the 
remaining 7.5% with secondary headache. Even similar results were 
obtained in the study done by Ade C longe et al 1998, where primary 
headache was diagnosed in 88%  of patients with chronic headache and 
secondary headache in remaining 12%.  
Of the 100 target population in the current study , 49% presented with 
Migraine and its variants, 23% with tension type , 4% with Mixed (Tension 
+Migraine), 5% with NDPH, 1% with cluster headache, 2% with post 
traumatic, 5% with post sinusitis , 5% with drug overuse , 1% with SOL and 
about 1% with Benign intracranial hypertension .(Table-2) 
This correlated well with the study done by Ade C Longe et al 1998, 
where about 43% presented with Migraine and its variants, 38% with tension 
type, 6.7% with Mixed migraine and tension type , 2.2% with post traumatic 
and about 2.2% with with pseudo tumour cerebri. 
Among the 82 patients with primary chronic headache , in the current 
study , Chronic Migraine was the most common type seen in 49 patients 
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(60%) followed by CTTH in 23 patients (28%)and about 5 patients(6%) 
presented with NDPH.(Table-3) This was comparable to the earlier study 
done by Chakravarthy et al 2003, who reported that 82% of the patients 
suffered from Migraine followed by 16% from CTTH and about 1.5% with 
NDPH. This was in contrast to the study done by Ravi et al 2007 who has 
reported CTTH as the most prevalent type. 
This profile of headaches in our study was in inverse correlation with 
many international studies .Epidemiological evidence from around the world 
suggests TTH is the most common cause of primary headache.  This 
variance is attributed to self treatment of tension type headaches by the 
general population. 
 Out of a total of 82 patients with chronic primary headache, 23 (28%) 
patients had chronic tension type headache , of which 2 (9%) patients 
presented with pericranial tenderness and the remaining 21 (91%) patients 
without pericranial tenderness (Table-5) 
 Among the 100 patients with chronic headache, current study revealed 
female predominance accounting for 66% (Table- 7) . Both in the primary 
and secondary headache group, females outnumbered males. Even there was 
no significant difference in the gender distribution among the patients with 
primary and secondary headaches. (Table-7a). 
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 Present study also revealed that females outnumbered males in 
number of cases of both tension type and migraine headache whereas male 
predominance among patients with NDPH and mixed type headache. Among 
the migraine patients, women seem to be more affected than men in a ratio 
about 2.3 :1. ( Table – 7b)  This was similar to the study done by Jain et al 
who showed a female dominance in both patients with migraine and tension 
type headache.  
 In this study , majority of the headache problems were observed in the 
population aged 21 to 40 years , the most productive age group which 
included patients of Migraine (59%) and Tension headache(74%) (Table-8) 
Even in the hospital based study done by A.P.Jain et al , majority involved 
the young population aged 21 to 40 years.  About 76.4% of the migraine and 
65.2% of the tension type headache patients were within this age group . 
 Current study revealed that almost 100% of the migraine patients 
presented with headache which was pulsating / throbbing in nature whereas 
96% of the tension headache with pressing (non- throbbing) type of 
headache. (Table -9 )This was comparable to the study done by Young chou 
et al 1996 where 87% of the migrainous patients presented with throbbing 
headache and about 72% of the patients with tension headache had headache 
which was non-throbbing in nature. 
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Inspite of the chronification of the headache , in this study, the 
intensity of pain was more severe  in about 98% of patients with Migraine 
headache whereas 69% of patients with CTTH had pain of moderate 
intensity.(Table -10) This was comparable to the study done by Young Chul 
Choi et al, where majority of migrainous patients presented with headache of 
severe intensity and majority of tension headache patients had pain of 
moderate intensity. 
 In this study, 51% of the migraine patients presented with bilateral 
headache and the remaining 49%  with unilateral headache. Majority of 
patients with tension and other primary headache disorder (except the patient 
with cluster headache ) , presented with bilateral headache as per the 
diagnostic criteria of ICHD-II. (Table -11)  Whereas in the study done by 
Young Chul Choi al 1996 , 70% of the migrainous patients presented with 
unilateral pain and about 63%  of tension headache patients had bilateral 
pain. 
 Majority of the migrainous and tension headache patients presented 
with headache at the fronto temporal area accounting for about 55% and 
60% respectively. (Table -12)  In the study done by A P Jain et al 2007, 
frontotemporal area is the most common site of migraine headache whereas 
tension type headache was situated all over the scalp. 
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         The majority of chronic headache patients were suffering from 
headache  for  around 15-25  days / month. However patients with NDPH 
presented with headache throughout the month .(Table-13) This explains the 
morbidity of chronic headache and also explains the poor quality of life in 
the sufferers.  
 In the current study, stress is the major aggravating factor in patients 
with  chronic tension type headache constituting about 78% . This is 
comparable to the study done by Chakravarthy et al , in which stress has 
been implicated as the aggravating factor for the development of CTTH in 
about 72.7% whereas 43.8% of the chronic migrainous patients had stress as 
the aggravating factor. 
Among the patients with migraine headache in the present study , 
stress has been implicated as the major aggravating factor in about 71% 
followed by noise , smell and lighting in about 16% , 2% and 14% 
respectively .(Table-14) 
         Symptoms such as nausea , vomiting , photophobia , blurring of vision 
were commonly associated with migraine headache . Among the patients 
with TTH , few had nausea, vomiting and blurring of vision . Lacrimation 
and rhinorrhea  were commonly associated with cluster headache.(Table-15) 
In the current study, CT Brain reveals normal study in almost majority 
of patients with chronic primary Headache . CT Brain of few patients 
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revealed  calcification and age related atrophy which are 
insignificant.(Table-17) As per ICHD-2 criteria primary headache is usually 
not associated with any structural abnormalities in the brain. 
         In this study , among the patients with secondary headache , CT Brain 
was normal in patients with medication overuse headache and post traumatic 
headache whereas CT PNS revealed sinusitis in almost all patients with post 
sinusitis headache.    
CT Brain in the patient with Benign intracranial hypertension showed 
dilated ventricles and CT of a 55year old male revealed a space occupying 
lesion on the right temporoparieto occipital region.(Table-18) 
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SUMMARY 
• Among the 100 patients with Chronic headache , Chronic primary 
headache was the most common type accounting for 82% 
• Chronic migraine headache was the most common type of chronic 
headache constituting 42% of the target population. 
• There was a female preponderance accounting for 66% of the target 
population. Females outnumbered males in both primary and 
secondary headache. 
• Majority of the study population belonged to the age group of 21 -40 
years. 
• Out of the 82 patients with chronic primary headache , 49 patients 
(60%) presented with Chronic  migraine followed by 23 patients 
(28%) with Chronic tension type headache. Mixed  
• Chronic migraine was the most common primary headache disorder .  
Majority of the patients presented with typical characteristics of 
headache such as  Pulsatile/ throbbing quality (100%) , severe 
intensity (98%) , Frontotemporal in location(55%), presenting around 
15-25 days/ month (98%) with out any structural lesions in CT brain.  
• CTTH was the second most common type of primary headache which 
commonly presented with pressing quality , moderate intensity, 
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bilateral in nature,  fronto temporal in location with normal study on 
CT brain. 
• STRESS   was the most common aggravating factor in  patients with 
chronic migraine as well as CTTH. 
• NEW DAILY PERSISTENT HEADACHE   was accounted for 6% 
of primary headache which commonly presented with Bilateral, 
moderate intensity with pressing quality which presents daily and 
remaining through out the day with out structural lesions in CT brain. 
• Out of 18 patients , medication overuse headache and post sinusitis 
headache were the most common type of secondary headache 
• Secondary headache most commonly seen in the age group of 21-40 
years with characteristic bilateral location, moderate to severe 
intensity with specific aggravating factors according to the type of 
headache with structural lesions noted in CT brain & paranasal 
sinuses. 
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CONCLUSION 
Headache in India is as important as any other neurological problem , 
and yet it is neglected . The study of headache is relatively simple and cheap 
compared to other neurological disorders. Prevalence data are essential. 
This study documents the profile of chronic headache patients and 
highlights the characteristics of headache and factors that predict headache 
associated morbidity. Although most patients suffered from  primary chronic 
headache requiring only clinical evaluation , CT scan is also necessary to 
reassure patients for the absence of an ominous structural intracranial 
lesions. 
To prevent misconceptions among doctors and to promote research , 
headache must be given greater importance in the medical curriculum. 
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CLINICAL PROFORMA 
 
 NAME    
 AGE 
 SEX 
 OCCUPATION 
 
CHIEF COMPLAINTS:- 
  HEADACHE                                                                            
  SITE 
  U/L OR B/L 
  MODE OF ONSET 
 THROBBING/PULSATING 
  INTENSITY  
  DURATION 
  RADIATION 
  LAST EPISODE 
  PERIODICITY 
  DAY/NIGHT 
  NO OF ATTACKS/MONTH 
ASSOCIATED SYMPTOMS:-   
  BLURRING OF VISION  
  PHOTOPHOBIA / PHONOPHOBIA 
  DIZZINESS  
  NAUSEA & VOMITING 
  AURA SYMPTOMS 
  LACRIMATION 
  RHINORRHOEA 
 AGITATION 
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  LOC 
  SEIZURES 
  NECK STIFFNESS 
  FOCAL NEUROLOGICAL DEFICIT 
                             MOTOR/ SENSORY 
AGGRAVATING FACTORS:- 
  LIGHTING 
  STRESS 
  NOISE 
  SMELLS 
  ALCOHOL 
  CAFFEINE 
  COUGH& COLD 
 
  H/O TRAUMA 
  H/O NECK PAIN 
  H/O FEVER 
  H/O REFRACTORY ERROR 
  H/O SINUSITIS 
  H/O DENTAL CARIES 
  H/O DEPRESSION/MOOD SWINGS 
 
PAST HISTORY 
  H/O TYPE2 DM 
  H/O CVA 
  H/O SHT 
  H/O DRUG INTAKE 
  H/O HEAD INJURY 
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  H/O SUBSTANCE ABUSE 
  H/O FEVER WITH NECK STIFFNESS 
  H/O SYSTEMIC ILLNESS 
 
MENSTURAL HISTORY 
 
EXAMINATION 
 
 GENERAL CONDITION:- 
 
 HIGHER FUNCTIONS:-  
 
  CRANIAL N:- 
   
              FUNDUS 
 
SPINO MOTOR   SYSTEM: 
 
 
               POWER 
 
          REFLEXES 
 
          PLANTAR 
 
SENSORY  
 
CEREBELLAR  
 
BOWEL& BLADDER  
 
SPINE & CRANIUM 
 
SCALP TENDERNESS 
 
 
ENT OPINION 
 
OPTHAL OPINION 
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PSYCHIATRY OPINION 
 
 
INVESTIGATIONS 
 
CT BRAIN 
 
CT PARANASAL SINUS 
 
MRI BRAIN 
 
 
IMPRESSION:- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
105 
 
ABBREVIATIONS 
 
 
CDH           Chronic Daily Headcahe 
CM Chronic Migraine 
CTTH    Chronic Tension type Headache 
NDPH New Daily Persistent Headache 
IHS   International Headache Society 
ICHD Internation Classification of Headache Disorders 
SSRI Selective Serotonin Reuptake Inhibitors 
CT Computed Tomography 
MRI  Magnetic Resonance Imaging 
EEG Electroencephalogram 
PET  Positron Emission Tomography 
ICP IntraCranial Pressure  
PNS  Paranasal Sinus 
DHE  Dihydro ergotamine 
NSAID Non Steroidal Anti Inflammatory Drugs 
CSF  Cerebro Spinal Fluid 
cGRP   Calcitonin gene related peptide 
CBF Cerebral Blood Flow 
SOL    Space Occupying Lesion 
 
